SCHEMBL4248196

SCHEMBL4248196

C[C@@]1(n2ccc(N)nc2=O)O[C@H](COOCP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.39
POLA1 P09884 1/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
P2RY2 P41231 3/20 0.38
POLB P06746 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
MTOR P42345 1/20 0.36
MDM2 Q00987 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
TSHR P16473 1/20 0.36
GLA P06280 1/20 0.36
PDE4D Q08499 1/20 0.34
PDE3A Q14432 1/20 0.34
SLC29A1 Q99808 1/20 0.34
P2RY4 P51582 2/20 0.34
P2RY6 Q15077 2/20 0.34
ST6GAL1 P15907 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12354843 0.87 POLA1 (0.44) POLA1P2RY2POLBLMNATHRB
SCHEMBL12363580 0.87 POLA1 (0.44) POLA1P2RY2POLBLMNATHRB
SCHEMBL13234931 0.87 POLA1 (0.44) POLA1P2RY2POLBLMNATHRB
SCHEMBL17027893 0.87 POLA1 (0.44) POLA1P2RY2POLBLMNATHRB
SCHEMBL13805632 0.86 POLA1 (0.38) FGFR1POLA1SLC22A6P2RY2POLB
SCHEMBL13815856 0.86 POLA1 (0.38) FGFR1POLA1SLC22A6P2RY2POLB
Phosphoric Acid SCHEMBL18438955 0.83 LMNA (0.47) FGFR1POLA1P2RY2POLBLMNA
Phosphoric Acid SCHEMBL17027889 0.83 LMNA (0.47) FGFR1POLA1P2RY2POLBLMNA
SCHEMBL12150893 0.82 FGFR1 (0.40) FGFR1POLA1SLC22A6P2RY2POLB
SCHEMBL18394211 0.82 P2RY2 (0.51) P2RY2POLBP2RY4P2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156545-A1 Substituted Phosphate Esters of Nucleoside Phosphonates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156545-A1 Substituted Phosphate Esters of Nucleoside Phosphonates PNP, TYMP, ENPP1 FGFR1 1039/4885POLA1 438/4885SLC22A6 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.